Human Knockout Carriers: Dead, Diseased, Healthy, or Improved?

Trends in Molecular Medicine

Volumn 22, Issue 4, 2016, Pages 341-351

  Narasimhan, Vagheesh M ^a   Xue, Yali ^a   Tyler Smith, Chris ^a  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

Clinical interpretation; Gene function; Loss of function variants

Indexed keywords

CLINICAL TRIAL (TOPIC); DISEASE COURSE; GENE FUNCTION; GENE INACTIVATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC DISORDER; HETEROZYGOTE; HOSPITAL; HUMAN; NONHUMAN; NORMAL HUMAN; PHENOTYPE; POPULATION GENETICS; REVIEW; BIOLOGY; GENE SILENCING; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETIC SELECTION; GENOME-WIDE ASSOCIATION STUDY; HUMAN GENOME; PROCEDURES;

COMPUTATIONAL BIOLOGY; GENE SILENCING; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENETICS, POPULATION; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HETEROZYGOTE; HUMANS; PHENOTYPE; SELECTION, GENETIC;

EID: 84960539555     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2016.02.006     Document Type: Review

References (72)

1. MacArthur D.G., Tyler-Smith C. Loss-of-function variants in the genomes of healthy humans. Hum. Mol. Genet. 2010, 19:R125-R130.
2. 1000 Genomes Project Consortium, et al. A map of human genome variation from population-scale sequencing. Nature 2010, 467:1061-1073.
3. Linderman M.D., et al. Analytical validation of whole exome and whole genome sequencing for clinical applications. BMC Med. Genomics 2014, 7:20.
4. Biesecker L.G., et al. Diagnostic clinical genome and exome sequencing. N. Engl. J. Med. 2014, 371:1169-1170.
5. McCarthy D.J., et al. Choice of transcripts and software has a large effect on variant annotation. Genome Med. 2014, 6:26.
6. Pruitt K.D., et al. NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res. 2005, 33:D501-D504.
7. Harrow J., et al. GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res. 2012, 22:1760-1774.
8. Yang H., Wang K. Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR. Nat. Protoc. 2015, 10:1556-1566.
9. McLaren W., et al. Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor. Bioinformatics 2010, 26:2069-2070.
10. Balasubramanian S., et al. Gene inactivation and its implications for annotation in the era of personal genomics. Genes Dev. 2011, 25:1-10.
11. Battle A., et al. Impact of regulatory variation from RNA to protein. Science 2015, 347:664-667.
12. Uzumcu A., et al. Loss of desmoplakin isoform I causes early onset cardiomyopathy and heart failure in a Naxos-like syndrome. J. Med. Genet. 2006, 43:e5.
13. Gilad Y., et al. Human specific loss of olfactory receptor genes. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:3324-3327.
14. Najmabadi H., et al. Deep sequencing reveals 50 novel genes for recessive cognitive disorders. Nature 2011, 478:57-63.
15. Wright C.F., et al. Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data. Lancet 2015, 385:1305-1314.
16. Deciphering Developmental Disorders Study Large-scale discovery of novel genetic causes of developmental disorders. Nature 2015, 519:223-228.
17. Ciancanelli M.J., et al. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency. Science 2015, 348:448-453.
18. Shamseldin H.E., et al. Lifting the lid on unborn lethal Mendelian phenotypes through exome sequencing. Genet. Med. 2013, 15:307-309.
19. Shamseldin H.E., et al. Identification of embryonic lethal genes in humans by autozygosity mapping and exome sequencing in consanguineous families. Genome Biol. 2015, 16:116.
20. Exome Aggregation Consortium, et al. Analysis of protein-coding genetic variation in 60,706 humans. bioRxiv 2015, Published online October 30, 2015. 10.1101/030338.
21. Fujikura K. Multiple loss-of-function variants of taste receptors in modern humans. Sci. Rep. 2015, 5:12349.
22. Samocha K.E., et al. A framework for the interpretation of de novo mutation in human disease. Nat. Genet. 2014, 46:944-950.
23. Akawi N., et al. Discovery of four recessive developmental disorders using probabilistic genotype and phenotype matching among 4,125 families. Nat. Genet. 2015, 47:1363-1369.
24. Fu W., et al. Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants. Nature 2013, 493:216-220.
25. Sulem P., et al. Identification of a large set of rare complete human knockouts. Nat. Genet. 2015, 47:448-452.
26. Lim E.T., et al. Distribution and medical impact of loss-of-function variants in the Finnish founder population. PLoS Genet. 2014, 10:e1004494.
27. Moltke I., et al. A common Greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes. Nature 2014, 512:190-193.
28. Jorde L.B., Pitkänen K.J. Inbreeding in Finland. Am. J. Phys. Anthropol. 1991, 84:127-139.
29. Saleheen D., et al. Human knockouts in a cohort with a high rate of consanguinity. bioRxiv 2015, 031518.
30. Narasimhan V.M., et al. Health and population effects of rare gene knockouts in adult humans with related parents. bioRxiv 2016, Science Published online March 3, 2016. 10.1126/science.aac8624.
31. Wang T., et al. Identification and characterization of essential genes in the human genome. Science 2015, 350:1096-1101.
32. Blomen V.A., et al. Gene essentiality and synthetic lethality in haploid human cells. Science 2015, 350:1092-1096.
33. Tong A.H.Y. Global mapping of the yeast genetic interaction network. Science 2004, 303:808-813.
34. Cooper D.N., et al. Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease. Hum. Genet. 2013, 132:1077-1130.
35. Stenson P.D., et al. Human Gene Mutation Database (HGMD): 2003 update. Hum. Mutat. 2003, 21:577-581.
36. Landrum M.J., et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 2014, 42:D980-D985.
37. Singh T., et al. Rare loss-of-function variants in KMT2F are associated with schizophrenia and developmental disorders. bioRxiv 2016, 036384.
38. Plon S.E., et al. Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum. Mutat. 2008, 29:1282-1291.
39. Thompson B.A., et al. Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database. Nat. Genet. 2014, 46:107-115.
40. MacArthur D.G., et al. Guidelines for investigating causality of sequence variants in human disease. Nature 2014, 508:469-476.
41. Quintáns B., et al. Medical genomics: the intricate path from genetic variant identification to clinical interpretation. Appl. Transl. Genomics 2014, 3:60-67.
42. Goldgar D.E., et al. Genetic evidence and integration of various data sources for classifying uncertain variants into a single model. Hum. Mutat. 2008, 29:1265-1272.
43. MacArthur D.G., et al. A systematic survey of loss-of-function variants in human protein-coding genes. Science 2012, 335:823-828.
44. Alsalem A.B., et al. Autozygome sequencing expands the horizon of human knockout research and provides novel insights into human phenotypic variation. PLoS Genet. 2013, 9:e1004030.
45. Blekhman R., et al. Natural selection on genes that underlie human disease susceptibility. Curr. Biol. 2008, 18:883-889.
46. Gao Z., et al. An estimate of the average number of recessive lethal mutations carried by humans. Genetics 2015, 199:1243-1254.
47. Hütter G., et al. Long-term control of HIV by CCR5 delta32/delta32 stem-cell transplantation. N. Engl. J. Med. 2009, 360:692-698.
48. Yang N., et al. ACTN3 genotype is associated with human elite athletic performance. Am. J. Hum. Genet. 2003, 73:627.
49. Xue Y., et al. Spread of an inactive form of caspase-12 in humans is due to recent positive selection. Am. J. Hum. Genet. 2006, 78:659-670.
50. Gurdasani D., et al. The African Genome Variation Project shapes medical genetics in Africa. Nature 2015, 517:327-332.
51. Plenge R.M., et al. Validating therapeutic targets through human genetics. Nat. Rev. Drug Discov. 2013, 12:581-594.
52. Pollin T.I., et al. A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection. Science 2008, 322:1702-1705.
53. Hall S.S. Genetics: a gene of rare effect. Nature 2013, 496:152-155.
54. Thompson P.L., et al. Targeting the unstable plaque in acute coronary syndromes. Clin. Ther. 2013, 35:1099-1107.
55. Lettre G. The search for genetic modifiers of disease severity in the β-hemoglobinopathies. Cold Spring Harb. Perspect. Med. 2012, 2:a015032.
56. Galarneau G., et al. Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation. Nat. Genet. 2010, 42:1049-1051.
57. Friend S.H., Schadt E.E. Clues from the resilient. Science 2014, 344:970-972.
58. Koonin E.V., Galperin M.Y. Genome annotation and analysis. Sequence - Evolution - Function, Computational Approaches in Comparative Genomics (Chapter 5) 2003, Kluwer Academic.
59. Rivas M.A., et al. Effect of predicted protein-truncating genetic variants on the human transcriptome. Science 2015, 348:666-669.
60. Ge Z., et al. Polypyrimidine tract binding protein 1 protects mRNAs from recognition by the nonsense-mediated mRNA decay pathway. Elife 2016, 5:e11155.
61. Kircher M., et al. A general framework for estimating the relative pathogenicity of human genetic variants. Nat. Genet. 2014, 46:310-315.
62. Ritchie G.R.S., et al. Functional annotation of noncoding sequence variants. Nat. Methods 2014, 11:294-296.
63. Miosge L.A., et al. Comparison of predicted and actual consequences of missense mutations. Proc. Natl. Acad. Sci. U.S.A. 2015, 112:E5189-E5198.
64. Petrovski S., et al. Genic intolerance to functional variation and the interpretation of personal genomes. PLoS Genet. 2013, 9:e1003709.
65. Itan Y., et al. The human gene damage index as a gene-level approach to prioritizing exome variants. Proc. Natl. Acad. Sci. U.S.A. 2015, 112:13615-13620.
66. Itan Y., et al. The mutation significance cutoff: gene-level thresholds for variant predictions. Nat. Methods 2016, 13:109-110.
67. Itan Y., et al. The human gene connectome as a map of short cuts for morbid allele discovery. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:5558-5563.
68. Simons Y.B., et al. The deleterious mutation load is insensitive to recent population history. Nat. Genet. 2014, 46:220-224.
69. Do R., et al. No evidence that selection has been less effective at removing deleterious mutations in Europeans than in Africans. Nat. Genet. 2015, 47:126-131.
70. Fu W., et al. Characteristics of neutral and deleterious protein-coding variation among individuals and populations. Am. J. Hum. Genet. 2014, 95:421-436.
71. Henn B.M., et al. Distance from sub-Saharan Africa predicts mutational load in diverse human genomes. Proc. Natl. Acad. Sci. U.S.A. 2016, 113:E440-E449.
72. Xue Y., et al. Mountain gorilla genomes reveal the impact of long-term population decline and inbreeding. Science 2015, 348:242-245.